INTRODUCTION {#sec1}
============

*Chlamydia* spp. are pathogens of humans and animals, infecting a wide range of tissues and anatomical sites and causing an equally wide range of disease states from host to host (Kaltenboeck [@bib18]; Batteiger [@bib1]). The manifestations of chlamydial infection include acute inflammatory reactions, chronic insidious disease and latent asymptomatic or 'persistent' infections. Variance in host response likely contributes to these disparate outcomes (Geisler *et al.*, [@bib11];Natividad *et al.*, [@bib27],[@bib24], [@bib25],[@bib26]; Wang *et al.*, [@bib43]) but little is known of how the variability of chlamydial pathogens allows for complicity in eliciting host responses or to enhance their chances for survival and subsequent transmission to a new host. On a global scale, the process of lateral gene transfer (LGT) allows for selection of new variants from related bacterial strains circulating within a host population. Evidence for LGT in *Chlamydiae* has been demonstrated but necessarily would only occur during mixed chlamydial infections (Gomes *et al.*, [@bib14], [@bib13]; DeMars *et al.*, [@bib9]; Jeffrey, Maurelli and Rockey [@bib17]).

In addition to LGT, another more refined adaptation that could be envisioned would be the presence of spontaneous mutations. Like all bacteria, chlamydiae exhibit spontaneous mutation as a natural process. Thus, in the context of a chlamydial population represented in the inoculum during a single transmission event, genomic variants that arise naturally would be amplified in select hosts or anatomical sites. Niche-specific selection has been demonstrated for *Chlamydia pneumoniae* (Gieffers *et al.*, [@bib12]) and several recent studies support the concept that variants likely exist within a single infectious population or inoculum. For example, Kari *et al.* ([@bib19]) showed that two separate isolates of *C. trachomatis*, serovar A, exhibited disparate *in vivo* and *in vitro* phenotypes thereby demonstrating that variances in virulence within a single serovar occurs. Subsequently, we have shown that the commonly used mouse pathogen, *C. muridarum*, contains at least two isolates that differ in their *in vitro* growth characteristics as well as their *in vivo* phenotype (Ramsey *et al.*, [@bib32]). Two clonal genomic variants were described from these isolates but we postulated that both strains were even more heterogeneous with regard to genotypic repertoire. Yeruva *et al.* ([@bib44]) more recently confirmed this postulate when they reported that one of these strains of *C. muridarum* (Nigg strain) in fact contained multiple genomic variants and that these often differed phenotypically both *in vitro* and *in vivo*. This was further confirmed at a recent international meeting on chlamydial infections (Sullivan *et al.*, [@bib41],[@bib42]). Similarly, a single ocular isolate from *C. caviae*-infected guinea pigs has been shown to contain genomic variant clones that differ in their sensitivity to azithromycin and exhibit disparate properties *in vitro* and *in vivo* (Binet *et al.*, [@bib2]). Lastly, Sturdevant *et al.* ([@bib38]) has shown that a single inoculum of *C. trachomatis*, serovar D, contains genomic variants that, when inoculated intravaginally into mice, display differing infection kinetics and eliciting disparate pathological outcomes.

It is important to note that in each of the aforementioned reports, the genomic variations identified were highly focused and limited in scope to small changes in a handful of genes---yet each was sufficient to significantly alter phenotype. Some of the predicted changes were in a relatively small number of non-synonymous mutations and thus resulting in alterations, deletions or insertion, of a single amino acid. In some cases, a frameshift in a gene was observed but in no case were wholesale gene deletions or substitutions observed. It cannot be discerned at this point whether these mutations were induced or amplified by cell culture passage as has been observed by some (Borges *et al.*, [@bib3]) or were present at the time of isolation of each of the relevant strains and preserved in culture passage; although, the concept of cell culture being an 'evolutionary freezer' for *Chlamydiae* has been proffered.

In the present study, we asked a more basic but related question with reference to specific chlamydial genes: Would the proportional representations of genomic variants in a chlamydial population change following passage in culture and through the natural host? To assess this possibility, we followed several previously identified single and multinucleotide polymorphisms (SNPs and MNPs) and insertion/deletion (indels) in two strains of *C. muridarum* following *in vitro* and *in vivo* passage through the mouse host. We will demonstrate that the representation of these different genomic variants within a population is dependent upon whether the population is passaged *in vitro* or *in vivo*.

MATERIALS AND METHODS {#sec2}
=====================

Mice, infections and infection monitoring {#sec2-1}
-----------------------------------------

Mice were purchased at 5--6 weeks of age and from the suppliers in Table [1](#tbl1){ref-type="table"} and allowed to acclimate in the Animal Resources Facility at Midwestern University for 10 days. Prior to urogenital infection, mice were treated with medroxyprogesterone acetate (Greenstone LLC, Peapack, NJ, USA) at 2.5 mg subcutaneously as has been described previously (Cotter *et al.*, [@bib6]). Seven days later, mice were infected with 10^4^ inclusion-forming units (IFU) of *C. muridarum* intravaginally (Cotter *et al.*, [@bib7]) in 10 μl volume. In order to verify and track genital infection, cervical--vaginal swabs were collected at 4 days post-infection, at day 7, 10, 14 and every 7 days thereafter through day 42. Swabs were placed in sucrose-phosphate-glutamic acid buffer (SPG, pH 7.2) and frozen at --80°C until isolations could be conducted. *Chlamydia muridarum* was isolated; inclusions visualized by indirect immunofluorescence and the presence of IFU in HeLa 229 cultures determined as previously described (Ramsey *et al.*, [@bib30]). All mice were euthanized on day 56, necropsied and tissues were examined *in situ* for gross macroscopic evidence of pyosalpinx or hydrosalpinx formation (Shah *et al.*, [@bib37]). All animal procedures were approved by the Midwestern University Institutional Animal Care and Use Committee.

###### 

Hydrosalpinx rates over time in inbred mice from various suppliers.

  Strain    Suppliers                    Percent hydrosalpinx (\# of oviducts assessed, \# experiments)   
  --------- ---------------------------- ---------------------------------------------------------------- ---------------------
                                         Historical - prior to 2006                                       Recent - since 2006
  BALB/c    Harlan Sprague Dawley        95 (40, 3)^a^                                                    73 (40, 2)
            Charles River Laboratories   nd                                                               88 (40, 2)
            Taconic Laboratories         nd                                                               78 (40, 2)
  C3H/HeN   Harlan-Sprague-Dawley        83 (219, 8)^b^                                                   35 (40, 2)
            Charles River Laboratories   nd                                                               50 (38, 2)
            Taconic Laboratories         nd                                                               35 (40, 2)

^a^Includes observations from unpublished data as well as published findings (Ramsey, DeWolfe and Salyer [@bib31]; Shah *et al.*, [@bib37]; Imtiaz *et al.*, [@bib16]; Lee *et al.*, [@bib21], [@bib20]).

*In vivo* passage scheme {#sec2-2}
------------------------

Serial *in vivo* passage was conducted by inoculating three progesterone-pretreated BALB/c mice intravaginally with stock cell-culture-derived *C. muridarum* as described above. At day 7 post-infection, cervical--vaginal swabs were collected, pooled into a single vial containing 500 μl of ice cold SPG and 3--5 sterile glass 2 mm beads. The vial was then vortexed vigorously for 30 s. Ten microliters of the resulting suspension was then used to inoculate three additional mice (passage A). Seven days later, the process was repeated and used to inoculate three additional mice (passage B). Following another 7 days, swabs were collected and pooled as before and the resulting suspension was frozen at --80° C (passage C). For the present study, plaque isolates from the third passage suspension were used for expansion and SNP-based genotyping assays.

*Chlamydia muridarum* growth, maintenance, clonal expansion and plaque assay {#sec2-3}
----------------------------------------------------------------------------

The *C. muridarum* strains used in this study were grown and maintained exactly as previously described (Ramsey *et al.*, [@bib32]). To derive clonal populations of *C. muridarum*, we used plaque assay in L929 mouse fibroblast monolayers grown in 6-well tissue culture plates exactly as described in Ramsey *et al.* ([@bib32]) and as adapted from O'Connell and Nicks ([@bib29]). Briefly, stock cultures of non-clonal *C. muridarum* strains or pooled swab samples following *in vivo* passage were diluted and inoculated onto confluent monolayers of L929 mouse fibroblasts in 6-well tissue culture plates in such a manner as to achieve ∼ 15--25 plaques per well. Following agarose-containing media overlay, the cells were incubated at 37°C in a humidified atmosphere of 5% CO~2~ for 4--5 days to allow plaques to form. Some plaques assays were plated separately for plaque size analysis at 4 days of incubation according to a previously published procedure (Ramsey *et al.*, [@bib32]). For genotyping, well-isolated plaques were selected for clonal expansion. Plaque material was aspirated using a micropipettor and placed in 100 μl of SPG and either frozen at --80°C or diluted in media, probe sonicated briefly and inoculated directly onto 25 cm^2^ tissue culture flasks containing confluent or near confluent monolayers of HeLa 229 cells. The flasks were rocked slowly at room temperature for 1 h in low total volume (∼1 ml) and then incubated for 1 h at 37°C. This was followed by aspiration and replacing the inoculum with fresh media and return to 37^o^C. The monolayers were then monitored for inclusion formation by scanning twice daily by inverted microscopy. Inclusions were often observed by 24--36 h and the flask was harvested when inclusion density subjectively reached at least 10% of the monolayer. In any case, no flask was maintained beyond 5 days without further passage and most were harvested within 36--72 h. The 25 cm^2^ flasks were harvested by scraping the monolayer, followed by probe sonication, and low-speed centrifugation (400 × g for 10 min at 4°C) to clear cellular debris. The supernatant was inoculated onto a fresh monolayer of HeLa 229 in one or two 75 cm^2^ flasks (based subjectively on inclusion density in the 25 cm^2^ flask) as above and monitored for growth as before until at least 10% inclusion density in the monolayer was attained.

For harvest of 75 cm^2^ flasks, the prior procedures were followed except that following low-speed centrifugation, the supernatant was centrifuged at 30 900 × g at 4°C for 30 min and the resulting pellet resuspended in SPG and frozen at --80° C. It should be noted that in most cases, once transferred to 75 cm^2^ flasks, expanded plaque isolates were harvested following a single round of replication. Thus, assuming a 30--36 h time to inclusion maturation, we estimate that the data derived from most plaque-clonal isolates in these studies are reported following no less than two and no more five rounds of replication *in vitro*.

Real-time polymerase chain reaction to detect targeted SNPs, MNPs and indels {#sec2-4}
----------------------------------------------------------------------------

Genomic DNA (gDNA) was extracted from a 500 μl SPG aliquot of the plaque-cloned isolates derived as described above using a commercially prepared kit according to the manufacturer\'s instructions (QIAMP DNA Mini Kit; Qiagen Inc, Valencia, CA, USA) All samples were analyzed using NanoVue Plus spectrometer (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA) for final DNA concentration. The gDNA samples were diluted to a final concentration of 50 μg μl^--1^ in DNase/RNase-free water and checked for chlamydia DNA by polymerase chain reaction (PCR) targeting the chlamydial major outer membrane protein (MOMP). We used 12.5 μl 2X Taqman^®^ Genotyping Master Mix (Life Technologies, Grand Island, NY, USA); MOMP forward (5^′^-TAGCCGAGACGTAGGCTGAT-3^′^) and reverse (5^′^-ATTAGCATTTGCCGTTTTGG-3^′^) primers (1 μl at 0.8 μM final concentration each); template gDNA (2 μl at 50 ng μl^--1^), and 8.5 μl RNAase/DNAase-free water for a total volume of 25 μl per tube. The PCR parameters were 2 min at 96°C; 40 cycles of 30 s at 96°C, 1 min at 57°C and 1 min at 72^o^C; and 5 min at 72^o^C. Each sample was run on a 1.5% Agarose gel to view 167 bp bands which confirmed the presence of chlamydial gDNA.

Targeted SNP, MNP and indel polymorphisms in the genome from published *C. muridarum* Nigg (GenBank database accession number NC_002620) (Read *et al.*, [@bib33]), Nigg2 (GenBank accession number ACOV01000000) or Weiss (GenBank accession number ACOW00000000) (Ramsey *et al.*, [@bib32]) strains were identified (Table [2](#tbl2){ref-type="table"}) and analyzed for application with TaqMan^®^ SNP Genotyping Assays (Applied Biosystems/Life Technologies, Grand Island, NY, USA). Primers were designed using the Custom TaqMan^®^ Assay Design Tool (https://www.lifetechnologies.com/order/custom-genomic-products/tools/genotyping/). The assays were designed with two allele-specific primer pairs and two probes with either 6-FAM or VIC dyes that bind the complementary allelic product utilizing the minor groove binder technology. The assay allows discrimination with probes as short as 13 bases and detection of binding is by exonuclease cleavage of the 5^′^ allele-specific dye label. Assays were run on 96-well PCR plates at 25 μl total volume (12.5 μl TaqMan^®^ Genotyping Master Mix; 1.25 μl custom designed assay primer/probe constituents; and 11.25 μl gDNA) in an ABI 7300 Real-time PCR machine programed with the following conditions: 95^o^C for 10 min, 92°C for 15 s and 60°C for 1 min for 40 cycles. All assays were checked for validity and every 96-well plate reaction was conducted with incorporated internal positive and negative controls (gDNA containing from variants known to contain the targeted allele or not) as well as no template controls (RNAase/DNAase-free water only) to assess for contaminating gDNA.

###### 

Section of non-synonymous SNPs, MNPs and indels assessed for population frequency in this study.

  ORF annotation     Gene description                                              NT change   AA change   References                                                                         Selection (reason)
  ------------------ ------------------------------------------------------------- ----------- ----------- ---------------------------------------------------------------------------------- -------------------------------------
  TC0052 (59062)     Major outer membrane protein, porin (*ompA*)                  GTT → DEL   C → DEL     Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   No (non-discrimination)
  TC0052                                                                                                                                                                                      
  \(59065\)          Major outer membrane protein, porin (*ompA*)                  C → T       S → F       Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32])                               No (non-discrimination)
  \- (126406)        intergenic                                                    G → DEL     NA          Read *et al.* ([@bib33]) Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])    No (Intergenic, non-discrimination)
  \- (126416)        intergenic                                                    INS → A     NA          Read *et al.* ([@bib33]) Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])    No (Intergenic, non-descrimination)
  \- (126475)        intergenic                                                    A → DEL     NA          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]) Yeruva *et al.* ([@bib44])    No (Intergenic)
  TC0124 (151212)    Transcription repair coupling factor (*trcF*)                 T → DEL     FS          Read *et al.* ([@bib33]) Ramsey *et al.* ([@bib32])                                Yes (used as control)
  TC0138 (169449)    phospho-N-acetylmuramoyl-pentapeptide- transferase (*mraY*)   INS → TTT   DEL → F     Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   Yes (variability present)
  TC0155 (187432)    3\`(2\`),5\`-bisphosphate nucleotidase, putative              G → A       H → Y       Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]) Yeruva *et al.* ([@bib44])    Yes (variably present)
  TC0168 (200671)    Ribosomal protein L34 (*RpmH*)                                G → C       T → R       Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   No (not confirmed by PCR)
  TC0341 (403623)    ABC transporter, permease protein, putative                   T → DEL     FS          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   No (non-discrimination)
  TC0341 (403626)    ABC transporter, permease protein, putative                   INS → C     FS          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32])                               No (non-discrimination)
  TC0341 (403652)    ABC transporter, permease protein, putative                   T → C       S → P       Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   No (not confirmed by PCR)
  TC0342 (404884)    ABC transporter, permease protein, putative                   A → DEL     FS          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   Nd
  TC0408 (468932)    Conserved hypothetical protein                                G → T       W → L       Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32])                               No (Not confirmed by PCR)
  TC0412 (473118)    Conserved hypothetical protein                                A → DEL     FS          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   Yes (variably present)
  TC0412 (473705)    Conserved hypothetical protein                                G → DEL     FS          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   Yes (variably present)
  TC0708 (846475)    Conserved hypothetical protein                                G → DEL     FS          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   Nd
  TC0727 (866121)    60 kDa outer membrane protein (*omcB*)                        G → T       G → C       Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   Yes (variably present)
  TC0832 (967487)    DNA polymerase II alpha subunit (*dnaE*)                      A → DEL     FS          Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32])                               Yes (variably present)
  TC0867 (1004276)   Hypothetical protein                                          T → C       S → P       Read *et al.* ([@bib33]), Ramsey *et al.* ([@bib32]), Yeruva *et al.* ([@bib44])   Yes (variably present)

Symbols: AA, amino acid; DEL, deletion; FS, frameshift; INS, insertion; NA, not applicable; Nd, not done; NT, nucleotide.

One-step growth rate determination for *C. muridarum* {#sec2-5}
-----------------------------------------------------

Clonal *C. muridarum* variants were inoculated at identical multiplicity of infection (0.1), based on the concentration of IFU in 0.5 ml of minimal essential media (MEM) onto monolayers of HeLa 229 in 24-well plates. The plates were centrifuged 1 h (1100 × g) at 35--37°C followed by 1 h of incubation at 37°C and media exchange to (MEM, 10% fetal bovine serum, 3 mg ml^--1^ added glucose and 0.5 μg ml^--1^ cycloheximide) (Ramsey *et al.*, [@bib32]). At 28 h following media exchange, the 24-well plate was frozen at --80^o^C. Upon thawing, the contents of each well were diluted and subcultured in an additional 24-well plate prepared with confluent HeLa 229 monolayers. Following identical incubation and centrifugation steps described above, the plate was incubated for an additional 28 h, media aspirated and the monolayers fixed in cold methanol for quantitative IFU determination as previously described (Ramsey *et al.*, [@bib32]).

Statistics {#sec2-6}
----------

The rate of hydrosalpinx formation and the frequency of genotypes were compared between groups using chi-square analysis with Yate\'s correction. One-step growth rate determination and plaque size were compared using a two-tailed *t-*test. Statistical significance was set at *P* ≤ 0.05.

RESULTS {#sec3}
=======

Rates of chronic disease in formerly susceptible strains of mice have declined over time following numerous *in vitro* passages {#sec3-1}
-------------------------------------------------------------------------------------------------------------------------------

Hydrosalpinx (fluid-filled, distended oviduct) is a chronic manifestation of *C. muridarum* infection in the mouse and has been used extensively as a surrogate marker of infertility (Su *et al.*, [@bib39]; Shah *et al.*, [@bib37]). Certain inbred strains of mice have long been known to be more susceptible to this outcome than other strains (De La Maza *et al.*, [@bib8]; Shah *et al.*, [@bib37]). To this end, our laboratory had previously used C3H/HeN mice as a standard for susceptible strains. However, beginning in approximately 2006, we observed a drop in the rate of hydrosalpinx formation following *C. muridarum* infection in this mouse strain. At first we thought this to be either an anomaly, a change in the virulence of *C. muridarum*, or possibly that a mutation in a critical gene or genes of the host that was responsible for this manifestation. Nevertheless, the observation was repeated on several attempts ruling out the possibility of an experimental anomaly. To rule out the latter possibility (a mutation in the host), we ordered both BALB/c and C3H/HeN mice from three common commercial suppliers. Over two experiments of 10 mice in each experiment (total of 20 mice and 40 oviducts assessed), we consistently observed a highly significant reduction in the rate of hydrosalpinx (Table [1](#tbl1){ref-type="table"}, *P* \< 0.001, chi-square analysis with Yates correction), when compared to historical controls and a slight but statistically significant drop in the rate of hydrosalpinx in the BALB/c susceptible strain (*P* \< 0.04). Because a spontaneous mutation in two or even one strain of mice from three separate suppliers is highly improbable, we interpreted these results to indicate that a less virulent variant(s) had arisen in our culture stocks of *C. muridarum*. Interestingly, although not directly addressed or compared across experiments, we did not note or observe quantitative (IFU counts over time) or qualitative (numbers of animals infected over time) differences in infection course kinetics in any strain of mice (data not shown). Thus, we interpreted this observation that infectivity had not been affected but some aspect of pathogenicity was altered within our *C. muridarum* stocks.

Design and initial evaluation of real-time PCR SNP-based multilocus genotyping assays {#sec3-2}
-------------------------------------------------------------------------------------

We hypothesized that a phenotypic change had occurred within our cell-culture-derived stocks of *C. muridarum* and that this change would be reflected in the genotype of selected variants isolated from these stocks. We further hypothesized that certain genotypic variants had arisen, possibly to predominance, in our stocks. To determine the proportional representations of genotypic variants in our cell-culture-derived stocks, we utilized the commercially available customized SNP-based real-time PCR. We selected polymorphism targets based on prior results of full genome sequencing of the Nigg and Weiss strains (Ramsey *et al.*, [@bib32]; Yeruva *et al.*, [@bib44]). See Table [2](#tbl2){ref-type="table"}. Some of the 20 non-synonymous polymorphisms previously identified were not further evaluated due to close spatial association that would likely lead to poor or no discrimination in the genotyping assays (e.g. TC_0052 and chromosomal positions 59062 and 59065 and TC_0341 at positions 403623 and 403626). Polymorphisms in the intergenic regions were also omitted from further assessment (e.g. three positions in TC_0107). We then designed our initial genotyping assays to include 12 of the remaining polymorphisms. In preliminary assessments of 24 isolates from cell-culture-derived *C. muridarum* (both Nigg and Weiss strains), some of the base changes identified previously (Ramsey *et al.*, [@bib32]; Yeruva *et al.*, [@bib44]) were constant, in that the original base at that position reported by Read *et al.* ([@bib33]) could not be replicated: TC_0168 (200671G\>C), TC_0341 (403652T\>C) and TC_0408 (468932TG\>T). We interpreted this finding to either be an error in the reading of the original sequence at that position or the mutation had subsequently become fixed in our culture stocks. Thus, these were not explored further. Of the remaining targets, a single open reading frame (ORF), TC_0412, contained two polymorphisms: at 473118delA and 473705delG. Both were predicted to result in a frameshift in this gene. Because these were spaced sufficiently to prevent non-discrimination, we targeted both polymorphisms in our assays and termed these TC_0412a and TC_0412b, respectively. Interestingly, the orthologous ORF in *C. trachomatis* (CT0135) has been shown to possess similar polymorphisms associated with attenuation or virulence in the mouse model of *C. trachomatis* urogenital infection and potentially inactivating mutations arise in this gene with prolonged cell culture passage (Sturdevant *et al.*, [@bib38]; Borges *et al.*, [@bib3]; Conrad, Chen and Zhong [@bib5]). Thus, we settled on eight final targets to assess polymorphisms in *C. muridarum*: TC_0124 (151212delT), TC_0138 (169449insTTT), TC_0155 (187432G\>A), TC_0412a (473118delA), TC_0412b (473705delG), TC_0727 (866121G\>T), TC_0832 (967487delA) and TC_0867 (1004276T\>C).

Genotypic proportional representation in chlamydial populations varies by strain and following *in vitro* vs *in vivo* passage {#sec3-3}
------------------------------------------------------------------------------------------------------------------------------

Our initial assessment of the proportions of the selected polymorphisms involved only plaque-cloned isolates derived from our stocks of *C. muridarum* that had a \>25 yr history of initial passage through embryonated hens eggs than an unknown number of passages through mammalian cell culture. The latter consisted mostly of HeLa 229 up to the point of the plaque assay and subsequently L929. A total of 55 randomly selected plaque isolates (30 of the Nigg strain and 25 from the Weiss) were minimally expanded *in vitro* for no less than two and no more than five passages after plaque selection and prior to genotyping. The qualified results of rtPCR reactions for each isolate for each polymorphism were one signal amplification reaction, indicating the presence of a single-specific allele (e.g. 151212delT or 151212T in TC_0124); two signal amplification reaction, indicating the presence of both alleles and interpreted as a mixed population of alleles at that position (e.g. both 187432G and 1187432A in TC_0155); or no amplification reaction or 'no call (NC)', interpreted as neither of the targeted alleles was present at that position for that isolate. The results of independent SNP frequencies in isolates are shown in Fig. [1](#fig1){ref-type="fig"} and the SNP pattern of the various isolates in Table [3](#tbl3){ref-type="table"}.

![Proportional representation of select polymorphisms in *C. muridarum* populations changes by strain and following *in vivo* passage. Each panel represents the qualitative results of rtPCR genotyping reactions targeting the specific polymorphism at each ORF and chromosomal position as labeled (upper-right corner of each panel). The proportional results of the reactions are presented in the bar graphs (allele legend in upper-left corner of each panel). Symbols common to all panels: -, no base at that position in originally sequenced *C. muridarum*; Del, deletion at that position in originally sequenced *C. muridarum*; NC, hatched bars ('no call' reaction indicating alternative allele not targeted by rtPCR primers is present in that reaction); gray bars---mixed reaction indicating presence of both alleles. Asterisks (\*) indicate significant difference (*P*-value specified in the text) between groups as determined by chi-square analysis with Yate\'s correction. Sample size: Nigg *in vitro*, *N* = 30; Weiss *in vitro*, *N* = 25; Nigg *in vivo*, *N* = 38; Weiss *in vivo*, *N* = 16.](ftv003fig1){#fig1}

###### 

Patterns of targeted SNPs in *C. muridarum* isolates in this study.

  Strain (N)^1^                      Polymorphisms *in vitro* passaged (chromosomal position)   Frequency                                                                                   
  ---------------------------------- ---------------------------------------------------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------- --------
                                     TC0124                                                     TC0138       TC0155       TC0412a      TC0412b      TC0727       TC0832       TC0867        
                                     \(151212\)                                                 \(169449\)   \(187432\)   \(473118\)   \(473705\)   \(866121\)   \(967487\)   \(1004276\)   
  Weiss (13)                         Del                                                        TTT/Del      G/A          Del          Del          T            Del          NC            .25
  Nigg (12)                          Del                                                        TTT/Del      G/A          Del          Del          T            Del          C             .23
  Weiss (7)                          Del                                                        TTT/Del      A            Del          Del          T            A            T/C           .13^2^
  Nigg (7)                           Del                                                        TTT          A            Del          Del          T            Del          C             .13
  Nigg (5)                           Del                                                        TTT          G/A          Del          Del          T            Del          C             .10
  Weiss (3)                          Del                                                        TTT/Del      A            Del          Del/G        G/T          A/Del        T/C           .06^3^
  Nigg (2)                           Del                                                        TTT          G/A          Del          G            T            Del          C             .04
  Nigg (2)                           Del                                                        TTT/Del      G/A          Del          NC           T            Del          C             .04
  Weiss (1)                          Del                                                        TTT/Del      G/A          NC           Del          T            Del          NC            .02
  Polymorphisms *in vivo* passaged                                                                                                                                                          
  Nigg (17)                          Del                                                        TTT/Del      A            A            G            G/T          Del          T/C           .28
  Weiss (12)                         Del                                                        TTT          G/A          Del          G            T            Del          T             .31
  Weiss (7)                          Del                                                        TTT          G/A          Del          G            T            Del          T             
  Nigg (7)                           Del                                                        TTT/Del      A            Del          Del          T            A            T/C           .11^2^
  Weiss (6)                          Del                                                        TTT/Del      G/A          Del          Del/G        G/T          A/Del        T             .10
  Nigg (5)                           Del                                                        TTT/Del      A            Del          Del/G        G/T          A            T/C           .08
  Weiss (3)                          Del                                                        TTT/Del      G/A          Del          G            T            Del          T             .05
  Nigg (2)                           Del                                                        TTT/Del      A            Del          Del/G        G/T          A/Del        T/C           .03^3^
  Nigg (2)                           Del                                                        TTT/Del      A            A            G            T            Del          T/C           .03

^1^Number of isolates of the strain with the stated SNP pattern (by rows).

^2^Identical SNP patterns at the stated loci in these isolates.

^3^Identical SNP patterns at the stated loci in these isolates.

Cell-culture-passaged Nigg and Weiss strains of *C. muridarum* (labeled '*in vitro'* in Fig. [1](#fig1){ref-type="fig"}) at six of the alleles showed no significant differences in allelic representation between the two strains. However, a significant difference was observed in the polymorphisms in two ORFs when comparing the Nigg and Weiss strains: TC_0138 (169449insTTT) and TC_0867 (1004276T\>C). Of note, amplification by primers targeting both allelic forms was commonly observed in TC_0138 (169449insTTT) and TC_0155 (187432G\>A) and also represented a substantive minority of the reactions in the Weiss strain for TC_0867 (10024276T\>C). This finding could be interpreted that the populations were not sufficiently clonal from the plaque selection phase of the process or that those loci exhibit a high frequency of mutation (a 'mutational hotspot') that quickly mutates following *in vitro* expansion. The latter possibility seems to be confirmed by the recent findings of Yervua *et al.*, who sequenced the genome of five *C. muridarum* (Nigg strain) isolates and identified identical SNPs at these positions (Yeruva *et al.*, [@bib44]). The majority of Weiss strain isolates did not contain either of these alleles at TC_0867 (10024276T\>C, 'NC' or no call in Fig. [1](#fig1){ref-type="fig"}), indicating a disparate polymorphism at that locus than what was targeted by genotyping reactions.

What could not be determined from these assessments is if any of these polymorphisms had changed over time since the initial isolation of *C. muridarum* (Gordon, Freeman and Clampit [@bib15]; Nigg [@bib28]). This would require an original 'wild-type' isolate of the pathogen or at least one that had minimal passage number which, to the best of our knowledge, is not available. However, we postulated that if genotypes more favorable for *in vivo* conditions were present in the population represented by our cell-culture-passaged stocks, they would be amplified following *in vivo* passage. We tested this hypothesis by blindly passaging the same polyclonal *C. muridarum* stocks used to isolate plaque isolates described above for three serial passages at 7-day intervals through the lower urogenital tract of mice as described in the section 'Materials and Methods'. Plaque isolates (38 from the Nigg strain and 16 from the Weiss strain) were then derived and minimally expanded in culture for SNP genotyping as above.

We found that the proportional representation of SNPs in seven of the eight assessed polymorphisms changed significantly with *in vivo* passage. The only polymorphism that did not change significantly with *in vivo* passage was TC_0124 (151212delT). This ORF encodes a putative transcription-repair coupling factor, *tcrF*, and the SNP is predicted to result in a frame shift in this gene. The deletion allele was found in predominance in all of our plaque isolates regardless of *in vitro* or *in vivo* passage. It is interesting to note that this SNP was not reported by Yeruva *et al.* in their genomic sequencing of five *C. muridarum* clonal variants that exhibited disparate *in vitro* and *in vivo* phenotypes. Neither was it reported in the originally sequenced Nigg strain of Read *et al.* ([@bib33]). It appears to be thus far unique to our laboratory.

The polymorphism in TC_0138 (169449insTTT), encoding a putative phospho-N-acetylmuramoyl-pentapeptide transferase, *mraY*), was originally identified in the second Nigg isolate genome to be sequenced (Nigg2) (Ramsey *et al.*, [@bib32]) and also in five of five subsequent Nigg strain variants that were sequenced by Yeruva *et al.* ([@bib44]). The latter finding is not terribly surprising since the Nigg strain from which the genomically sequenced Nigg2 was derived was originally provided to us by the Rank and Yeruva laboratory (Ramsey *et al.*, [@bib32]). In our lab, the frequency of this polymorphism varied significantly between the Weiss and Nigg strain prior to *in vivo* passage. As would be anticipated, a majority of the Nigg isolates contained the TTT insertion when compared to the Weiss isolates (*P* \< 0.001), although a substantial minority of Nigg strain isolates showed mixed amplification indicating the presence of both alleles in these isolates (gray bars in TC_0138 panel of Fig. [1](#fig1){ref-type="fig"}). The *in vitro* passaged Weiss isolates were nearly all mixed with regard to the presence or absence of either allele, with only a single isolate possessing a pure population containing the absence of the insertion. Interestingly, following *in vivo* passage, proportions of this polymorphism changed significantly in both Nigg (*P* \< 0.001) and Weiss (*P* \< 0.002) strains but in a manner that was not uniform between the two strains. Conversely, with reference to *in vitro* passage, a greater percentage of Nigg strain isolates expressed both alleles while the Weiss isolates possessing the insTTT allele increased significantly following *in vivo* passage.

The ORF at TC_0155 encodes a putative 3^′^(2^′^),5^′^-bisphosphate nucleotidase and contains a non-synonymous SNP at position (187432G\>A) corresponding to amino acid change in histidine to tyrosine residues (Ramsey *et al.*, [@bib32]; Yeruva *et al.*, [@bib44]). An additional non-synonymous SNP in this ORF at position 187984C\>T in a single *C. muridarum* variant has also been reported by Yeruva *et al.* ([@bib44]), but is not assessed herein. Isolates of both cell-culture-passaged Nigg and Weiss strains encoding the A allele and mixed A and G alleles were present in similar proportions (*P* = 0.384, black and gray bars, respectively) with a single isolate detected that contained the G only allele in each strain. Following *in vivo* passage, the A allele predominated in the Nigg strain isolates (*P* \< 0.001) while all isolates of the Weiss strain had mixed population at the allele (*P* \< 0.001).

The SNPs in TC_0412a (473118delA) and TC_0412b (473705delG) represent potentially function-disrupting frameshift mutations. Similar findings have been reported for the orthologous *C. trachomatis* gene, and these alterations were also shown to affect infectivity and virulence in the mouse (Sturdevant *et al.*, [@bib38]). We observed that the majority of isolates from cell-culture-passaged Nigg and Weiss strain *C. muridarum* exhibited the deletion alleles in both TC_0412a and TC_0412b. Interestingly, a single isolate out of 30 Nigg strain and none of the 25 Weiss strain isolates exhibited the parental allele at TC_0412a. However, one Weiss strain isolate exhibited an NC reaction thereby indicating that an undetermined alternative allele was present at low frequency. Following *in vivo* passage, there was a significant shift to predominance in the parental allele at TC_0412a in the Nigg strain (*P* \< 0.001) isolates whereas the Weiss strain isolates all contained the deletion allele---likely indicating that the originating cell-culture-derived Weiss strain either no longer contained the parental allele or that it was exceedingly rare at the outset. In TC_0412b, again the deletion allele was in majority in the population cell-culture-passaged stocks of both Nigg and Weiss strains, but upon *in vivo* passage the population of variants in this allele shifted to predominance of the parental allele (*P* \< 0.001 for both Nigg and Weiss strains). Of note were two isolates with NC reactions at this allele in the Nigg strain and a substantive minority containing reactions for both alleles in the Weiss strain prior to *in vivo* passage and in both strains following *in vivo* passage.

The TC_0727 (*omcB*) gene encodes the 60 kDa cysteine-rich outer membrane protein, which is common to *Chlamydiae* and has been shown in *C. trachomatis* and *C. pneumoniae* to have adhesin properties (Fechtner *et al.*, [@bib10]). The SNP at position 866121G\>T was first identified by us when sequencing isolates from the Nigg and Weiss strains (Ramsey *et al.*, [@bib32]) and was later confirmed by Yeruva *et al.* in the sequencing of five *C. muridarum* Nigg variants. While a majority of isolates of both cell-culture-passaged strains possessed the T substitution allele, after *in vivo* passage, there was a substantive shift to mixed expression of both the parental G and substitution T allele which achieved statistical significance with the Nigg strain (*P* \< 0.001) but the proportional difference was smaller in the Weiss strain and was not significantly different.

The ORF annotated as TC_0832 encodes the alpha subunit of DNA polymerase III (*dnaE*). We have previously reported the presence of an SNP (967487delA) resulting in a putative frameshift mutation in an isolate of the Weiss strain (Ramsey *et al.*, [@bib32]). In the present study, the majority of cell-culture-derived isolates of both Nigg and Weiss strains contained the deletion allele. *In vivo* passage significantly increased the presence of the parental allele in the Nigg strain (*P* \< 0.001) but a mixture of both alleles predominated in isolates of the Weiss strain, representing a significant change from the proportions present in the cell-culture-derived isolates (*P* \< 0.033).

Lastly, TC_0867 is an ORF encoding a conserved hypothetical protein (Read *et al.*, [@bib33]). The Nigg strain has been reported to possess a non-synonymous SNP which is a substitution at position 1004276T\>C resulting in a change from a serine to a proline (Ramsey *et al.*, [@bib32]). More recently, the presence of this SNP was confirmed in three of five Nigg strain isolates (Yeruva *et al.*, [@bib44]). Confirming these prior observations, we detected the C allele present in a majority of cell-culture-passaged Nigg isolates but that a significant shift in the proportion of isolates exhibiting this allele was observed following *in vivo* passage with a mix of both the C and T alleles resulting (*P* \< 0.001). In the cell-culture-derived Weiss strain, we observed a majority of isolates expressed neither C nor T alleles (NC), with only a single isolate of 25 assessed exhibiting the T allele and 10 of 25 the C allele. Again, this changed significantly with all Weiss strain isolates derived from in *vivo* passage expressing the parental T allele (*P* \< 0.001).

*In vitro* phenotypic changes in selected isolates {#sec3-4}
--------------------------------------------------

We next sought to determine if there were detectable phenotypic variances within these isolates. One measure of *in vitro* phenotype that has been reported is plaque size (O'Connell and Nicks [@bib29]; Kari *et al.*, [@bib19]; Ramsey *et al.*, [@bib32]; Yeruva *et al.*, [@bib44]). Indeed, we had begun to notice that plaque size became more uniform following *in vivo* passage, particularly in isolates of the Nigg strain while plaques of the Weiss isolates did not appear to vary to the same degree following *in vivo* passage. Fig. [2](#fig2){ref-type="fig"} confirms this observation. The Nigg strain plaques were highly variable following the first *in vivo* passage (mean area = 0.67 +/-- 0.21 mm^2^, range = 0.97 mm^2^, *N* = 62), exhibiting greater size and range of plaque area when compared to the first passage of the Weiss strain (mean area = 0.39 +/-- 0.14 mm^2^, range = 0.69 mm^2^, *N* = 60). At the second subsequent *in vivo* passage, the mean area of the Nigg strain plaques became significantly smaller and more uniform than the plaques formed following the first passage (mean area = 0.56 +/--0.18 mm^2^, range = 0.84 mm^2^, *N* = 59, *P* \< 0.001, two-tail *t* test) while the Weiss strain plaques did not vary significantly in size from the first passage. By the third passage *in vivo*, the Nigg strain plaques had further decreased in area (mean area 0.50 +/-- 0.16 mm^2^, range = 0.63 mm^2^, *N* = 60) although this decrease did not quite achieve statistical significance (*P* = 0.07). Also, by the third passage, there was no longer a statistically significant difference in the size of the Nigg and Weiss plaques. These data indicated that *in vivo* passage of *C. muridarum* induced an *in vitro* phenotypic change in the population of isolates within the Nigg but not the Weiss strain. It should be noted that the plaque assays and the related results were conducted simultaneously following inoculation of mice from polyclonal cell-culture-passaged stocks of *C. muridarum* and without knowledge of the constituent genotypic population in the originating inocula.

![Plaque size changes with *in vivo* passage. Filled circles represent the results for the Nigg strain and open circle represents the results for the Weiss strain. Horizontal bar is the mean for each group at each *in vivo* passage. The *P-*values were determined by a two-tailed *t* test and are shown in the figure for strain comparison at each *in vivo* passage (*N* = 58--62 for each strain and passage). Comparing with Weiss plaque size did not change significantly with *in vivo* passage but the Nigg strain yielded smaller plaques at the first and second *in vivo* passage (*P* \< 0.001 comparing the first passage with the second *in vivo*). By the third passage, Nigg isolates had again decreased in size but this did not prove to be significant (*P* \< 0.07).](ftv003fig2){#fig2}

In order to assess if any of the identified genotypic variants exihibited *in vitro* phenotypic changes, we then selected four genotypic plaque variants (CM005, CM006, CM014 and CM022; SNP pattern shown in bottom table in Fig. [3](#fig3){ref-type="fig"}): two each from the *in vitro* and *in vivo* passaged isolates. We selected these variants based on similar SNP patterns predominating *in vitro* only (CM005 and CM006) in addition to one majority (CM014) and one minority (CM022) isolate genotype pattern observed following *in vivo* passage. The isolates were subjected to a one-step growth rate analysis (also called elementary body or 'EB burst rate'). These results are shown in the top panel of Fig. [3](#fig3){ref-type="fig"}. Variant CM006 exhibited a significantly slower growth rate than for the other three isolates (*P* \< 0.0001 vs CM005 and CM014; *P* = 0.004 vs CM022 using a two-tailed *t* test). Among the remaining isolates, variant CM014 displayed a faster growth rate than CM022 (*P* = 0.0007).

![*In vitro* phenotypic variance of *C. muridarum* isolates. The top panel represents the results of a one-step growth rate determination of four isolates. The results shown are that of two experiments, six replicates per isolate per experiment (*N* = 12). The asterisk (\*) in the top panel indicates that variant CM006 growth yielded significantly fewer viable EBs at the same MOI and over the same incubation when compared to the other isolates. The number sign in the top panel (\#) indicates that there was also a significantly greater EB yield in variant CM014 when compared to CM022. The bottom panel represents the plaque size analysis of the same variants (one experiment, *N* = 240). The asterisk (\*) in the bottom panel indicates that variant CM005 yielded significantly smaller plaques than all other variants. The number sign (\#) indicates that CM006 produced smaller plaques than CM022 (*P* = 0.038). The table in the bottom of the figure shows the SNP pattern for each of the four *C. muridarum* variants and the frequency at which they were found *in vitro* or *in vivo*.](ftv003fig3){#fig3}

The bottom panel in Fig. [3](#fig3){ref-type="fig"} shows that these same variants also produced disparate cytopathic effects relative to plaque size. Variant CM005 produced consistently smaller plaques than any of the other isolates (*P* \< 0.0001 for each using a two-tailed *t* test), and variant CM006 also produced smaller plaques than CM022 (*P* = 0.038). It should be noted that this is not the first report that plaque size does not necessarily correlate with the yield of viable EBs (Ramsey *et al.*, [@bib32]; Yeruva *et al.*, [@bib44]).

We conclude from these findings that these isolates varied significantly in growth rate and plaque size phenotype. However, the differences observed cannot yet be ascribed to the affected polymorphisms unless the genomes of candidate variants were sequenced and any polymorphisms observed confirmed to be restricted to the ones reported herein. Full genomic sequencing of the isolates would also likely reveal other polymorphisms that vary with *in vivo* adapation. Hence, the ones we have demonstrated that change with *in vivo* passage are not at all likely to be exclusive.

DISCUSSION {#sec4}
==========

It is now quite clear that the known laboratory-passaged *C. muridarum* exist as a population of multiple genotypic variants that exhibit equally diverse *in vitro* and *in vivo* phenotypes (Ramsey *et al.*, [@bib32]; Yeruva *et al.*, [@bib44]; Sullivan *et al.*, [@bib41],[@bib42]). Similarly, solid evidence exists that subtle changes in the *C. trachomatis* and *C. caviae* genome can have similar profound effects in mice and lower primates and in guinea pigs, respectively (Kari *et al.*, [@bib19]; Binet *et al.*, [@bib2]; Sturdevant *et al.*, [@bib38]). These small variances in genome have been associated with changes in growth rate, plaque size, inclusion morphology, infectivity and survivability in the host; virulence and the induction of pathological immune responses; and the differences in the rate of ascension from lower to upper genital tract. It is becoming obvious that subtle changes in the genome have more than a subtle impact on the phenotype of this pathogen. This is not surprising in that chlamydial pathogens have small genomes, likely reflecting a reductionist adaptation to the intracellular environment (Clarke [@bib4]). Hence, few 'dispensable' genes remain and changes in those that remain may make profound differences.

Nonetheless, caution should be exercised in interpreting the present results. We still are not certain of the genotypic composition of most original chlamydial clinical isolates that have been sequenced, including *C. muridarum.* This is an important point for if we are to truly understand chlamydial pathogenesis, we should know the composition of the initial inoculum presented to a host in a natural context and whether or not this composition will determine the outcome of the inoculation event in a particular host or at a particular anatomical site. Some encouraging progress has recently been made that may shed light on this. For example, Seth-Smith *et al.* ([@bib35], [@bib36]) has demonstrated that whole-genome sequences can be derived from clinical samples using a combination of immunomagnetic separation and multiple displacement amplification). These types of studies will be important in understanding genomic variability of a chlamydia population in a single inoculum in a natural setting.

A recent study by Borges *et al.* ([@bib3]) has shed light on chlamydial genomic variability over time in cell culture. Using a prototypical *C. trachomatis*, L2, strain L2 434/Bu, with a long history of culture in hen\'s eggs and mammalian cell culture, and a recent clinical isolate of the same serovar, they followed the genomes for a year in continuous culture. They found a low mutation rate over the monitoring period (10^−9^ to 10^−10^ per base per generation). One should remember, however, that the *C. muridarum* strains used in the present study were isolated in the 1930s and 1940s and have been passaged countless times in cell culture and in hen\'s eggs before that. Thus, these isolates predate the historical prototypical isolate of L2 utilized by Borges *et al.* by ---two to three decades and untold numbers of passages (Schachter and Meyer [@bib34]). In this sense, it is also important to note that the rate of mutation is apparently quite low in *C. muridarum*. Amongst the eight total isolates sequenced thus far, there is a high degree of homology and changes are largely focused to the polymorphisms described above in Table [1](#tbl1){ref-type="table"} (Read *et al.*, [@bib33]; Ramsey *et al.*, [@bib32]; Conrad, Chen and Zhong [@bib5]; Yeruva *et al.*, [@bib44]). The evidence would suggest that the polymorphisms are mutational hotspots. Our observations could reasonably be ascribed to selection of pre-existing favorable SNPs because we did not observe the appearance of any new SNPs in the form of new NC following *in vivo* passage. All NC reactions were only present in the *in vitro* passaged isolates.

With reference to specific polymorphisms, it is interesting that Borges *et al.* observed the same inactivating mutation in the putative virulence factor in *C. trachomatis*, serovar L2, CT135, as reported by Sturdevant *et al.* for serovar D (Sturdevant *et al.*, [@bib38]; Borges *et al.*, [@bib3]). Our results herein and previously confirm these findings (Ramsey *et al.*, [@bib32]; Yeruva *et al.*, [@bib44]). It seems that this gene in *C. trachomatis* and the orthologous *C. muridarum* gene TC_0412 degenerate quickly in cell culture (Conrad, Chen and Zhong [@bib5]). Our present results show that if minority variants in cell culture with intact TC_0412 remain, they are amplified following *in vivo* passage. One should note, however, that while select variants from both *in vitro* and *in vivo* passage exhibit phenotypic differences *in vitro*, we have yet to determine *in vivo* fitness or virulence associated with the polymorphisms in any of the isolates assessed in the present study. These studies will require sequencing the genomes of each such variant tested in order to confirm, or not, the stability of the polymorphism and whether or not the remainder of the genome has changed. Nonetheless, previous studies indicate that these polymorphisms are present in the original and parental Nigg and Weiss strains and these indeed exhibit virulence and fitness differences (Ramsey *et al.*, [@bib32]). Also, in a separate study, clonal genotypic variants of *C. muridarum* with defined genomic composition and similar SNP patterns displayed significant virulence and fitness differences (Yeruva *et al.*, [@bib44]).

We should also point out that the use of plaque assay to derive isolates could exhibit a negative selective pressure for non-plaque forming isolates and thereby skew genotyping results. While non-plaque forming phenotype has not yet been described for *C. muridarum*, we cannot rule this out.

We feel that the greatest importance of the present study is the finding that selected polymorphisms are amplified or enriched following recent *in vivo* passage thereby implying that *in vivo* fitness is associated with one allele over the other. This proves that genomic representation in a chlamydial population is indeed dynamic and adaptive based on conditions presented to them. It would certainly be of interest to obtain a fresh or low passage number isolate of *C. muridarum* to sequence and compare to the variants we have now but this has not been forthcoming. It is safe to say that one must be careful in interpretations of data using chlamydial strains that have been passaged repeatedly in cell culture.

That selection occurs *in vivo* is of paramount importance. *Chlamydiae* are programed for survival in the host, so the genes that are retained *in vivo* may be key to survival in the host environment in contrast to living in the stress-free environment of a cell culture where they are not needed and thus dispensed (Sturdevant *et al.*, [@bib38]; Borges *et al.*, [@bib3]; Conrad, Chen and Zhong [@bib5]). However, it should also be noted that, even *in vivo*, the organism may be required through selection to modify its gene repertoire. One cannot forget that every host will be genetically different and every anatomic site may exhibit different pressures and this may have a significant effect on the pathologic outcome of the infection (Miyairi *et al.*, [@bib23], [@bib22]; Su *et al.*, [@bib40]). Therefore, we suggest that the pathologic outcome of chlamydial infection is dependent upon both the chlamydial variant selected *in vivo* and the genetic makeup of the host. Likewise, the host response and physiologic parameters specifically associated with the host genotype may have a profound effect on the variants comprising the chlamydial population, and this may alter in transmission to a new genetically different host.
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